Back to Studies

P1005 / T-20 in HIV-1 Infected Children.

A Phase I/II Study of T-20, A Fusion Inhibitor, in HIV-1 Infected Children

Study Status

Concluded

DAIDS Number

10314

IND Number

58,681

Primary Protocol Team Members

Joseph Church Study Chair

Coleen Cunningham Study Chair

Summary

A Phase I/II Study of T-20, a Fusion Inhibitor, in HIV-1-Infected Children

Loading study documents...

Loading study sites...

Loading study protocol team...

Loading study press...

Loading study publications/presentations...